Literature DB >> 2754016

A radioimmunoassay for bradykinin based on monoclonal antibodies.

E Phillips1, M Webb.   

Abstract

We describe two monoclonal antibodies with recognise the peptides bradykinin and kallidin. These antibodies were used in a study to assess the feasibility of using monoclonal antibodies in place of conventional sera for radioimmunoassay. Antibody SBK1 recognises bradykinin with a Kd of 0.67 +/- 0.17 nM. It fails to recognise bradykinin from which any carboxyl terminal amino acid has been removed. Antibody SBK2 recognises bradykinin with a Kd of 58.11 +/- 7.55 nM; it recognises 1-8 and 1-7 bradykinin about 30% as effectively as the full-length sequence, and shorter carboxyl terminal truncated sequences with a progressively declining efficiency. In this model system, bradykinin concentrations of 0.2 nM could be reliably measured, and carboxyl truncated versions of the peptide could be distinguished from the parent molecule. The feasibility of using monoclonal antibodies to assay bradykinin and other small peptides is discussed in the light of these results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754016     DOI: 10.1016/0165-5728(89)90049-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  1 in total

1.  Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.

Authors:  M Majima; K Nishiyama; Y Iguchi; K Yao; M Ogino; T Ohno; N Sunahara; K Katoh; N Tatemichi; Y Takei; M Katori
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.